Agarwal C,Bansal K,Pujani M,Singh K,Chauhan V,Rana D,Lukhmana S D .2019 .Association of coagulation profile with microvascular complications and glycemic control in type 2 diabetes mellitus - A study at a tertiary care center in Delhi. Hematol Transfus Cell Ther. , 41(1) : 31-36.
Abouammoh NA,Alshamrani MA .2020 .Knowledge about diabetes and glycemic control among diabetic patients in Saudi Arabia. J. Diabetes Res., : 1-6.
Antunes BM,Rossi FE,Oyama LM,Rosa-Neto JC,Lira FS .2020 .Exercise intensity and physical fitness modulate lipoproteins profile during acute aerobic exercise session. Sci. Rep, 10(1) : 1-8.
Chen R,Yan J,Liu P,Wang Z,Wang C .2017 .Plasminogen activator inhibitor links obesity and thrombotic cerebrovascular diseases: The roles of PAI1 and obesity on stroke. Metab. Brain Dis, 32(3) : 667-673.
Dastgheib SA,Najafi F,Shajari A,Bahrami R,Asadian F,Sadeghizadeh-Yazdi J,Akbarian E,Emarati SA,Neamatzadeh H SA .2020 .Association of plasminogen activator inhibitor-1 4G5G Polymorphism with risk of diabetic nephropathy and retinopathy: A systematic review and meta-analysis. JDMD, : 1-12.
El Wakeel MA,Abou-El-Asrar Mohamed,El-Kassas GM,Elabd MA,Zeid DA,Sabry RN,Awadallah EMAN .2017 .Urinary markers of oxidative DNA damage in Type 1 diabetic children: Relation to microvascular complications. Asian J. Pharm. Clin. Res., 10(10) : 318-22.
El Sayed ZH,Ismail SM,ELhakeem HA SM .2018 .Evaluation of plasma fibrinogen and plasminogen activator inhibitor-1 in type 2 diabetes mellitus patients with coronary artery disease. SSAMFG, 2(3) : 252.
Wolfrum Grandl G,C Grandl G .2018 .February. Hemostasis, endothelial stress, inflammation, and the metabolic syndrome. Semin Immunopathol, 40(2) : 215-224.
Jung RG,Simard T,Labinaz A,Ramirez FD,Di Santo P,Motazedian P,Rochman R,Gaudet C,Faraz MA,Beanlands RS,Hibbert B .2018 .Role of plasminogen activator inhibitor-1 in coronary pathophysiology. Thromb. Res,, 164 : 54-62.
Lee SJ,Hong JM,Lee SE,Kang DR,Ovbiagele B,Demchuk AM,Lee JS .2017 .Association of fibrinogen level with early neurological deterioration among acute ischemic stroke patients with diabetes. BMC Neurology, 17(1) : 1-7.
Liu S,Li Y,Fan X,Li K,Xu C,Zhang L,Luo M,Wang L,Li R,Wu J .2020 .Transplantation of adipose tissue lacking PAI-1 improves glucose tolerance and attenuates cardiac metabolic abnormalities in high-fat diet-induced obesity. Adipocyte, 9(1) : 170-178.
Persil-Ozkan O,Yigit E,Yigit Z E .2019 .Does weight loss affect the parameters that are metabolically related to cardiovascular diseases? Saudi Med. , 40(4) : 347.
Razak MKA,Sultan AA .2019 .The importance of measurement of plasma fibrinogen level among patients with type-2 diabetes mellitus. Diabetes Metab Syndr Clinical Research & Reviews, 13(2) : 1151-1158.
Recinella L,Orlando G,Ferrante C,Chiavaroli A,Brunetti L,Leone S L .2020 .Adipokines: New potential therapeutic target for obesity and metabolic, rheumatic, and cardiovascular diseases. Front. Physiol., 11 : 1-32.
Song C,Burgess S,Eicher JD,'Donnell O,Johnson CJ,AD CJ,Sabater-Lleal Huang J,M Huang J .2017 .Causal effect of plasminogen activator inhibitor type 1 on coronary heart disease. J. Am. Heart Assoc., 6(6) : e004918.
Mohiuddin SS .2018 .Correlation of glycemic status with plasma fibrinogen level in insulin dependent as well as noninsulin dependent diabetic patients. J. Endocrinol. Diab., 5(5) : 1-6.
Somodi S,Seres I,Lorincz H,Harangi M,Fulop P,Paragh G .2018 .Plasminogen activator inhibitor-1 level correlates with lipoprotein subfractions in obese nondiabetic subjects. Int. J. Endocrinol., (-3) : 1-9.
Sobolewski K,Radparvar S,Wong C,Johnston J .2018 .Blood, blood components, plasma, and plasma products. Side Eff. Drugs Annu, 40 : 415-429.
Shemran KA .2051 .Study the elevation of fibrinogen level in plasma patients with diabetes mellitus type 2 in babylon governorate. Indian J. Forensic Med, 14(4) : .
Tabakcı MM,Gerin F,Sunbul M,Toprak C,Durmus HI,Demir S,Arslantas U,Cersit S,Batgerel U,Kargın R U .2017 .Relation of plasma fibrinogen level with the presence, severity, and complexity of coronary artery disease. Clin. Appl, 23(6) : 638-644.
Vousden KA,Lundqvist T,Popovic B,Naiman B,Carruthers AM,Newton P,Johnson DJ,Pomowski A,Wilkinson T,Dufner P,de Mendez I P .2019 .Discovery and characterisation of an antibody that selectively modulates the inhibitory activity of plasminogen activator inhibitor-1. , 9(1) : 1-12.
Zhang J,Wang Y,Zhang R,Li H,Han Q,Wu Y,Wang S,Guo R,Wang T,Li L,Liu F L .2018 .Serum fibrinogen predicts diabetic ESRD in patients with type 2 diabetes mellitus. Diabetes Res. Clin. Pract, 141 : 1-9.